Stifel cuts BridgeBio Oncology price target to $15 from $23
Benzinga/TradingView reports Stifel cut its BridgeBio Oncology price target to $15.00 per share from $23.00.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Benzinga/TradingView reports Stifel cut its BridgeBio Oncology price target to $15.00 per share from $23.00.